{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:51Z","timestamp":1762854171780,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"am","delay-in-days":391,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.gofs.2018.12.012","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T07:39:53Z","timestamp":1548574793000},"page":"123-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Valeur diagnostique de l\u2019imagerie (\u00e9chographie, doppler, scanner, IRM et TEP-TDM) pour le diagnostic d\u2019une masse ovarienne suspecte et le bilan d\u2019extension d\u2019un cancer de l\u2019ovaire, des trompes ou p\u00e9riton\u00e9al primitif. Article r\u00e9dig\u00e9 sur la base de la recommandation nationale de bonnes pratiques cliniques en canc\u00e9rologie intitul\u00e9e \u00ab\u00a0Conduites \u00e0 tenir initiales devant des patientes atteintes d\u2019un cancer \u00e9pith\u00e9lial de l\u2019ovaire\u00a0\u00bb \u00e9labor\u00e9e par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l\u2019\u00e9gide du CNGOF et labellis\u00e9e par l\u2019INCa"],"prefix":"10.1016","volume":"47","author":[{"given":"I.","family":"Thomassin-Naggara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"L\u00e9curu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.12.012_bib0325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejogrb.2014.10.012","article-title":"Management of presumed benign ovarian tumors: updated French guidelines","volume":"183","author":"Brun","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.12.012_bib0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2016.01.007","article-title":"Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis","volume":"58","author":"Meys","year":"2016","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2018.12.012_bib0335","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/uog.13437","article-title":"Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis","volume":"44","author":"Nunes","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0340","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/uog.11088","article-title":"Prospective evaluation of the IOTA logistic regression model LR2\u00a0for the diagnosis of ovarian cancer","volume":"40","author":"Nunes","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0345","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tjog.2014.05.002","article-title":"The risk of malignancy index (RMI) in women with adnexal masses in Wales","volume":"53","author":"Abdulrahman","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7863\/ultra.15.01068","article-title":"Performance of the risk of malignancy index for discriminating malignant tumors in women with adnexal masses","volume":"35","author":"Campos","year":"2016","journal-title":"J Ultrasound Med"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0355","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2014.10.017","article-title":"Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer","volume":"135","author":"Moore","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/uog.12551","article-title":"Are serum HE4\u00a0or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?","volume":"43","author":"Kaijser","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.12.012_bib0365","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00404-013-2901-1","article-title":"Usefulness of the HE4\u00a0biomarker as a second-line test in the assessment of suspicious ovarian tumors","volume":"288","author":"Moszynski","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gofs.2018.12.012_bib0370","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/803598","article-title":"Borderline ovarian tumors and diagnostic dilemma of intraoperative diagnosis: could preoperative He4\u00a0assay and ROMA score assessment increase the frozen section accuracy? A multicenter case-control study","author":"Gizzo","year":"2014","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0375","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/humupd\/dmt059","article-title":"Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis","volume":"20","author":"Kaijser","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.gofs.2018.12.012_bib0380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2015.05.024","article-title":"Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence","volume":"191","author":"Ruiz de Gauna","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.gofs.2018.12.012_bib0385","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajog.2016.01.007","article-title":"Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group","volume":"214","author":"Timmerman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.12.012_bib0390","doi-asserted-by":"crossref","first-page":"c6839","DOI":"10.1136\/bmj.c6839","article-title":"Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group","volume":"341","author":"Timmerman","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0395","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2013.04.003","article-title":"A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses","volume":"130","author":"Sayasneh","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2018.12.012_bib0400","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jgyn.2013.09.029","article-title":"MRI and CT-scan in presumed benign ovarian tumors","volume":"42","author":"Thomassin-Naggara","year":"2013","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.214.1.r00ja3939","article-title":"Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis","volume":"214","author":"Hricak","year":"2000","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0410","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1148\/radiol.2361041618","article-title":"Indeterminate ovarian mass at US: incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis","volume":"236","author":"Kinkel","year":"2005","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.gofs.2018.12.012_bib0415","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00330-007-0842-4","article-title":"Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses","volume":"18","author":"Tsili","year":"2008","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0420","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ygyno.2013.10.022","article-title":"Pelvic M.R.I. as the \u201cgold standard\u201d in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review","volume":"132","author":"Anthoulakis","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0425","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3348\/kjr.2014.15.1.72","article-title":"Multidetector computed tomography for the assessment of adnexal mass: is unenhanced CT scan necessary?","volume":"15","author":"Jung","year":"2014","journal-title":"Korean J Radiol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0430","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/IGC.0000000000000074","article-title":"Diagnostic value of preoperative SUVmax on FDG-PET\/CT for the detection of ovarian cancer","volume":"24","author":"Tanizaki","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2018.12.012_bib0435","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00259-017-3638-z","article-title":"An update on the role of PET\/CT and PET\/MRI in ovarian cancer","volume":"44","author":"Khiewvan","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.gofs.2018.12.012_bib0440","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","article-title":"Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer","volume":"83","author":"Michielsen","year":"2017","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2018.12.012_bib0445","first-page":"171","article-title":"MRI for the diagnosis of ultrasonographically indeterminate pelvic masses","volume":"64","author":"Anwar","year":"2014","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0450","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jmri.24740","article-title":"MRI for differentiating primary fallopian tube carcinoma from epithelial ovarian cancer","volume":"42","author":"Ma","year":"2015","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00330-009-1584-2","article-title":"ESUR Female Imaging Sub-Committee. ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach","volume":"20","author":"Spencer","year":"2010","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0460","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.10100751","article-title":"Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging","volume":"258","author":"Thomassin-Naggara","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0465","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jmri.21377","article-title":"Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors","volume":"28","author":"Thomassin-Naggara","year":"2008","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0470","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13048-017-0302-y","article-title":"The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors","volume":"10","author":"Li","year":"2017","journal-title":"J Ovarian Res"},{"issue":"1053","key":"10.1016\/j.gofs.2018.12.012_bib0475","doi-asserted-by":"crossref","first-page":"20150099","DOI":"10.1259\/bjr.20150099","article-title":"Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?","volume":"88","author":"Mansour","year":"2015","journal-title":"Br J Radiol"},{"issue":"1043","key":"10.1016\/j.gofs.2018.12.012_bib0480","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130730","article-title":"Use of an internal reference in semi-quantitative dynamic contrast-enhanced MRI (DCE MRI) of indeterminate adnexal masses","volume":"87","author":"Tang","year":"2014","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.gofs.2018.12.012_bib0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149465","article-title":"The value of diffusion-weighted imaging in the differential diagnosis of ovarian lesions: a meta-analysis","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.gofs.2018.12.012_bib0490","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00330-009-1299-4","article-title":"Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses","volume":"19","author":"Thomassin-Naggara","year":"2009","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.gofs.2018.12.012_bib0495","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.13121161","article-title":"Adnexal masses: development and preliminary validation of an MR imaging scoring system","volume":"267","author":"Thomassin-Naggara","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.gofs.2018.12.012_bib0500","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejogrb.2016.07.493","article-title":"External validation of the MR imaging scoring system for the management of adnexal masses","volume":"205","author":"Ruiz","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2018.12.012_bib0505","doi-asserted-by":"crossref","DOI":"10.5152\/dir.2018.17378","article-title":"Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses","author":"Pereira","year":"2018","journal-title":"Diagn Interv Radiol"},{"issue":"7","key":"10.1016\/j.gofs.2018.12.012_bib0510","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/IGC.0000000000000203","article-title":"Correlation of pelvic magnetic resonance imaging diagnosis with pathology for indeterminate adnexal masses","volume":"24","author":"Haggerty","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2018.12.012_bib0515","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejrad.2017.04.001","article-title":"for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis","volume":"91","author":"Denewar","year":"2017","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.gofs.2018.12.012_bib0520","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00330-016-4533-x","article-title":"Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour","volume":"27","author":"Kurata","year":"2017","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.gofs.2018.12.012_bib0525","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00261-014-0325-4","article-title":"Magnetic resonance imaging findings of mucinous borderline ovarian tumors: comparison of intestinal and endocervical subtypes","volume":"40","author":"Woo","year":"2015","journal-title":"Abdom Imaging"},{"issue":"9","key":"10.1016\/j.gofs.2018.12.012_bib0530","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s00330-014-3236-4","article-title":"imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation","volume":"24","author":"Zhao","year":"2014","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","article-title":"A multicenter assessment of the ability of preoperative computed tomography scan and CA-125\u00a0to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer","volume":"145","author":"Suidan","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2018.12.012_bib0540","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00330-013-3083-8","article-title":"with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET\/CT","volume":"24","author":"Michielsen","year":"2014","journal-title":"Eur Radiol"},{"issue":"997","key":"10.1016\/j.gofs.2018.12.012_bib0545","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1259\/bjr\/87415692","article-title":"Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer","volume":"84","author":"Chandrashekhara","year":"2011","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0550","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer: correlation between PET\/CT. Doppler US, and CT or MRI","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2018.12.012_bib0555","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","article-title":"Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.gofs.2018.12.012_bib0560","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ygyno.2013.08.022","article-title":"Detection of nodal metastases by 18F-FDG PET\/CT in apparent early stage ovarian cancer: a prospective study","volume":"131","author":"Signorelli","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0565","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00259-011-1984-9","article-title":"Prognostic significance of mediastinal 18F-FDG uptake in PET\/CT in advanced ovarian cancer","volume":"39","author":"Bats","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0570","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/0284186X.2010.500296","article-title":"uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer","volume":"50","author":"Risum","year":"2011","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1016\/j.gofs.2018.12.012_bib0575","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/IGC.0b013e3182606ecb","article-title":"Positron emission tomography\/computed tomography predictors of overall survival in stage IIIC\/IV ovarian cancer","volume":"22","author":"Risum","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2018.12.012_bib0580","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00330-010-1736-4","article-title":"Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3T","volume":"20","author":"Roy","year":"2010","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.gofs.2018.12.012_bib0585","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.ultrasmedbio.2016.05.014","article-title":"Prospective evaluation of ultrasound accuracy in the detection of pelvic carcinomatosis in patients with ovarian cancer","volume":"42","author":"Weinberger","year":"2016","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.gofs.2018.12.012_bib0590","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/uog.15942","article-title":"Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study","volume":"49","author":"Fischerova","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0595","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1148\/rg.233025712","article-title":"US of the peritoneum","volume":"23","author":"Hanbidge","year":"2003","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.gofs.2018.12.012_bib0600","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","article-title":"Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group","volume":"215","author":"Tempany","year":"2000","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.gofs.2018.12.012_bib0605","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0610","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2005.07.123","article-title":"Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2018.12.012_bib0615","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/1471-0528.12992","article-title":"Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer","volume":"122","author":"Borley","year":"2015","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0620","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.04.013","article-title":"Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer","volume":"138","author":"Janco","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2018.12.012_bib0625","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajog.2005.03.058","article-title":"Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer","volume":"193","author":"Everett","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.12.012_bib0630","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.20376","article-title":"The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma","volume":"101","author":"Dowdy","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2018.12.012_bib0635","first-page":"369","article-title":"Can pre-operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy?","volume":"109","author":"Byrom","year":"2002","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.gofs.2018.12.012_bib0320","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2018.12.012_bib0640","first-page":"CR667","article-title":"Potential of CT-scan based tumor volume as a response indicator in chemotherapy of advanced epithelial ovarian cancer","volume":"8","author":"Kumar","year":"2002","journal-title":"Med Sci Monit"},{"issue":"9","key":"10.1016\/j.gofs.2018.12.012_bib0645","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0284185115620947","article-title":"Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis","volume":"57","author":"Qiu","year":"2016","journal-title":"Acta Radiol"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0650","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1148\/radiol.11110577","article-title":"Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients","volume":"261","author":"Kyriazi","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0655","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.11110175","article-title":"Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects","volume":"263","author":"Sala","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0660","first-page":"81","article-title":"[18F]FDG-PET\/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy","volume":"55","author":"Martoni","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0665","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2015.10.018","article-title":"18F-FDG-PET\/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer","volume":"140","author":"Vallius","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2018.12.012_bib0670","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.2001.6246","article-title":"Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy","volume":"82","author":"Rose","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"30","key":"10.1016\/j.gofs.2018.12.012_bib0675","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1200\/JCO.2005.06.965","article-title":"Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer","volume":"23","author":"Avril","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918303805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918303805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:38:26Z","timestamp":1762853906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918303805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2468718918303805"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.12.012","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valeur diagnostique de l\u2019imagerie (\u00e9chographie, doppler, scanner, IRM et TEP-TDM) pour le diagnostic d\u2019une masse ovarienne suspecte et le bilan d\u2019extension d\u2019un cancer de l\u2019ovaire, des trompes ou p\u00e9riton\u00e9al primitif. Article r\u00e9dig\u00e9 sur la base de la recommandation nationale de bonnes pratiques cliniques en canc\u00e9rologie intitul\u00e9e \u00ab\u00a0Conduites \u00e0 tenir initiales devant des patientes atteintes d\u2019un cancer \u00e9pith\u00e9lial de l\u2019ovaire\u00a0\u00bb \u00e9labor\u00e9e par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l\u2019\u00e9gide du CNGOF et labellis\u00e9e par l\u2019INCa","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}